July 28, 2010
Posted by admin
A major step toward the first-ever FDA-approved clinical trial using human embryonic stem cells.
Today ACT put out the announcement, below.
ACT Files Documentation With FDA for Clinical Trials Using ES Cells to Treat Eye Disease
This development should help the company take a major step toward initiation of its Phase I/II trial later this year, which would be the first-ever FDA-approved clinical trial using human embryonic stem cells (hESCs).
This development [...]